RSS

new chemical entities (NCEs)

Evonik Industries has broadened its capabilities in finished drug product formulation and clinical supply manufacturing and can now handle drug products containing HPAPIs in Darmstadt, Germany, and Birmingham, Alabama, US. Investments in high... more

Technology

To meet rising demand for high potency active pharmaceutical ingredients (HPAPIs) spurred by the growing targeted therapy approach in the treatment of diseases, in particular oncology, Switzerland-based CARBOGEN AMCIS has completed a capital... more

Technology